Business Description
Aspira Womens Health Inc
NAICS : 334516
SIC : 3841
ISIN : US92407M2061
Description
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1 | |||||
| Equity-to-Asset | -0.53 | |||||
| Debt-to-Equity | -0.85 | |||||
| Debt-to-EBITDA | -0.13 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -164.37 | |||||
| Beneish M-Score | -5.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.7 | |||||
| 3-Year EBITDA Growth Rate | 8.5 | |||||
| 3-Year EPS without NRI Growth Rate | 9.7 | |||||
| 3-Year FCF Growth Rate | 8.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 48.98 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 58.35 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 13.26 | |||||
| 9-Day RSI | 17.18 | |||||
| 14-Day RSI | 19.87 | |||||
| 3-1 Month Momentum % | -57.63 | |||||
| 6-1 Month Momentum % | -63.39 | |||||
| 12-1 Month Momentum % | -90.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.75 | |||||
| Quick Ratio | 0.7 | |||||
| Cash Ratio | 0.39 | |||||
| Days Inventory | 24.89 | |||||
| Days Sales Outstanding | 59.28 | |||||
| Days Payable | 170.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.1 | |||||
| Shareholder Yield % | 173.96 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.12 | |||||
| Operating Margin % | -189.47 | |||||
| Net Margin % | -165.07 | |||||
| FCF Margin % | -162.79 | |||||
| ROA % | -240.12 | |||||
| ROIC % | -1049.7 | |||||
| 3-Year ROIIC % | 286.51 | |||||
| ROC (Joel Greenblatt) % | -2358.07 | |||||
| ROCE % | -1946.64 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.22 | |||||
| EV-to-EBIT | -0.18 | |||||
| EV-to-EBITDA | -0.18 | |||||
| EV-to-Revenue | 0.33 | |||||
| EV-to-Forward-Revenue | 0.13 | |||||
| EV-to-FCF | -0.21 | |||||
| Price-to-GF-Value | 0.04 | |||||
| Price-to-Median-PS-Value | 0.01 | |||||
| Earnings Yield (Greenblatt) % | -555.56 | |||||
| FCF Yield % | -494.61 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AWH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aspira Womens Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 8.963 | ||
| EPS (TTM) ($) | -1.2 | ||
| Beta | 0.76 | ||
| 3-Year Sharpe Ratio | -0.93 | ||
| 3-Year Sortino Ratio | -1.22 | ||
| Volatility % | 68.33 | ||
| 14-Day RSI | 19.87 | ||
| 14-Day ATR ($) | 0.055549 | ||
| 20-Day SMA ($) | 0.29224 | ||
| 12-1 Month Momentum % | -90.45 | ||
| 52-Week Range ($) | 0.1581 - 4.2909 | ||
| Shares Outstanding (Mil) | 17.68 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aspira Womens Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aspira Womens Health Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aspira Womens Health Inc Frequently Asked Questions
What is Aspira Womens Health Inc(AWH)'s stock price today?
The current price of AWH is $0.17. The 52 week high of AWH is $4.29 and 52 week low is $0.16.
When is next earnings date of Aspira Womens Health Inc(AWH)?
The next earnings date of Aspira Womens Health Inc(AWH) is 2025-03-28 Est..
Does Aspira Womens Health Inc(AWH) pay dividends? If so, how much?
Aspira Womens Health Inc(AWH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers